Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 AUD | -2.78% | -5.41% | -2.78% |
Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Sales 2024 * | 11.81M 7.76M | Sales 2025 * | 17.97M 11.81M | Capitalization | 80.61M 53M |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.18M | Net income 2025 * | -16M -10.52M | EV / Sales 2024 * | 5.09 x |
Net cash position 2024 * | 20.45M 13.44M | Net cash position 2025 * | 17.07M 11.22M | EV / Sales 2025 * | 3.54 x |
P/E ratio 2024 * |
-4.62
x | P/E ratio 2025 * |
-4.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.75% |
1 day | -2.78% | ||
1 week | -5.41% | ||
Current month | -5.41% | ||
1 month | -12.50% | ||
3 months | +12.90% | ||
6 months | -18.60% | ||
Current year | -2.78% |
Managers | Title | Age | Since |
---|---|---|---|
Luke Reid
CEO | Chief Executive Officer | - | - |
James Heath
DFI | Director of Finance/CFO | - | - |
Yao Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Capone
BRD | Director/Board Member | 61 | 21-03-17 |
Director/Board Member | - | 22-09-07 | |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.175 | -2.78% | 19 744 300 |
24-05-08 | 0.18 | 0.00% | 3,000 |
24-05-07 | 0.18 | 0.00% | 95 |
24-05-06 | 0.18 | 0.00% | 43,700 |
24-05-03 | 0.18 | -2.70% | 14,712 |
Delayed Quote Australian S.E., May 09, 2024 at 01:32 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.78% | 52.99M | |
-17.08% | 8.39B | |
+45.61% | 3.74B | |
-36.69% | 2.55B | |
-8.41% | 2.48B | |
-12.90% | 2.32B | |
-6.49% | 1.93B | |
-17.24% | 1.6B | |
-37.21% | 1.28B | |
+5.14% | 1.08B |
- Stock Market
- Equities
- MAP Stock